An interventional study of Hands-free exoskeleton in Spinal Cord Injuries (SCI) and Paraplegia and Tetraplegia, sponsored by Wandercraft. Completed at 2 sites in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-29.
Sponsored by Wandercraft · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 968 studies in Spinal Cord Injuries with a site in United States — 249 open to participants now, 308 under way, 7 of them phase 3. Spinal Cord Injuries · United States.
Among the 968 studies in Spinal Cord Injuries with a site in United States, this one is the 367th largest by enrollment of the 836 interventional ones that give a count, is one of 57 that started in 2025, is one of 601 with no phase, and was the 859th registered.
2,032 studies on the registry are indexed under Spinal Cord Injuries; 542 are open to participants now.
Browse Spinal Cord Injuries studies →249 of the 968 studies in Spinal Cord Injuries with a site in United States are open now. Recruiting first, the newest first:
Medical University of South Carolina · Sites in United States
Ages 18–70
Johns Hopkins University · Sites in United States
Ages 18–80
University of Miami · Sites in United States
Ages 22–70
Kessler Foundation · Sites in United States
Ages 22+
Neuralink Corp · Sites in United States
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 374 Spinal Cord Injuries studies recruiting now, 167 (45%) set no upper age limit and 156 (42%) stop at 75 or younger; 40 take children under 18; 52 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
968 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 94 · Phase 2 132 · Phase 3 39 · Phase 4 27
First in 1986; this study’s year is marked. 57 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 27 is above the median of 24 across 1,639 interventional studies indexed under Spinal Cord Injuries.
Median enrollment 24 across the 836 interventional studies, 58 across the 128 observational. Of the 576 that completed or were terminated, 225 (39%) have results posted.
This tab as a report to print or save as PDF → With an account.
75 of 968 have an industry lead sponsor. The 10 most frequent:
Wandercraft is the lead sponsor of 14 studies on the registry; 5 are open to participants now.
Wandercraft has 8 studies filed under Spinal Cord Injuries — fewer than ten, so there is no comparison to draw.
117 of the studies in Spinal Cord Injuries with a site in United States that are under way reach primary completion within a year, 2 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05903859Phase 3University of MiamiImprovement of Reproductive Function in Men With Spinal Cord Injury (SCI) | 2027-05-31 |
| NCT07625332Phase 3Northwell HealthPilot Study of Galantamine to Treat Metabolic Syndrome in People With Chronic Traumatic Spinal Cord Injury (SCI) | 2027-08 |
| NCT03930056Shirley Ryan AbilityLabC-Brace II Spinal Cord Injury | 2026-11 |
| NCT04077346University of LouisvilleNeuromodulation of Spinal Locomotor Circuitry to Elicit Stepping After Pediatric Spinal Cord Injury | 2026-11 |
| NCT05423600Virginia Commonwealth UniversityTransspinal Stimulation With and Without Blood Flow Restricted Exercise Via Telehealth in Persons With Tetraplegia | 2026-11 |
Add all 117 to your calendar (.ics) → With an account.
Among the 968 studies in Spinal Cord Injuries with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study aims to demonstrate the safety and effectiveness of the personal exoskeleton in individuals with spinal cord injury (SCI).
This personal exoskeleton, developed by Wandercraft as a new version of the Atalante X, offers a novel hands-free and self-balancing design, aiming at enhancing stability and mobility for users in daily activities.
The study features an interventional, prospective, single-group, and open-label design, conducted over 3 to 4 weeks at two US research facilities. 24 subjects are required to complete the study. Anticipating a 15% dropout rate, the study will enroll 29 participants.
Over the course of nine to ten scheduled visits, participants undergo a sequence of procedures, beginning with screening and device fitting. This is followed by five training sessions which conclude with an evaluation to issue a competency certificate to confirm the ability to use the device across all its "basic skills". Additionally, two sessions are dedicated to evaluating the exoskeleton's effectiveness outcomes, complemented by an extra practice session. Each visit lasts an average of 1.5 hours.
SCI user inclusion Criteria:
SCI user exclusion Criteria:
Companion inclusion Criteria:
Companion exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Device: Hands-free exoskeleton
A "device trainer specialist" from the investigation site will deliver training sessions with the exoskeleton to pair of participants (a pair corresponds to an individual with SCI and his/her companion). The device trainer will follow the progression of the pair through the training program and ensure they learn all the device "basic skills". Each training session lasts an average of 1.5 hours, variations according to the user's learning pace and tolerance. During the sessions with the exoskeleton, the participants will engage in mobility activities on different surfaces and perform Activities of Daily Living in simulated environments such as kitchen, bathroom, elevators and outdoor spaces.
Proportion of subjects who complete the Timed Up and Go (TUG) in 3min or less.
The TUG evaluates the time from starting in a seated position to stand-up, walk 3 meters, turn around, walk back 3 meters and sit down on indoor surface.
Time frame: At visit 7, after an average of 7.5 hours of training and at visit 9, after an average of 9 hours of training.
Proportion of subjects who complete a distance of at least 40m on the Six-Minute Walk Test (6MWT).
The 6MWT measures the distance in meters traversed over 6 min, on indoor surface.
Time frame: At visit 7, after an average of 7.5 hours of training and at visit 9, after an average of 9 hours of training.
Proportion of subjects who can complete at least 4 out of the 6 Activities of Daily Living (ADLs), in various simulated environments and with the exoskeleton.
The ADLs are done standing in front of the countertop in the kitchen, in a simulated living room, taking a 50m walk in the outdoor environment, taking the elevator, in the bathroom and walking in a hallway and through a door to get to the next room.
Time frame: At visit 7, after an average of 7.5 hours of training and at visit 9, after an average of 9 hours of training.
Proportion of subjects who complete the 10-Meter Walk Test (10MWT) on indoor surfaces in 1 minute or less.
The 10MWT measures the time in seconds taken to walk 10 meters.
Time frame: At visit 7, after an average of 7.5 hours of training and at visit 9, after an average of 9 hours of training.
Proportion of subjects who can don or doff the device within 10 minutes each, separately.
Time frame: At visit 7, after an average of 7.5 hours of training and at visit 9, after an average of 9 hours of training.
Proportion of users who pass the device "basic skills" certification evaluation at the end of visit 6.
During the Certification Evaluation, the users' performance in executing all the device usability critical tasks will be observed and assessed by the trainer to ensure they are performed correctly (i.e., executed safely, regardless of the level of companion assistance, that is documented but isn't a criterion for success). The "basic skills" certification evaluation is passed if all the device basic skills have been learnt through the previous training sessions with the device (visits 2-5) and the critical tasks are re-executed correctly during the evaluation at visit 6. The device basic skills cover device theoretical knowledge, proper setup and installation in the device, walking and other ambulatory functions on different surfaces, Activities of Daily Living in indoor and outdoor environment techniques on various surfaces, and safety features such as emergency extraction
Time frame: Throughout the study and up until the end of Visit 6, after an average of 7.5 hours of training.
Number of users who successfully master the different basic skills at a given visit
For each basic skill, the visit number at which users are confirmed to have safely mastered the task is recorded on a "checklist", which lists all the device basic skills and is provided to the trainer. The goal is to track the users' learning progress and mastery of the device over time.
Time frame: Throughout the study and up until the end of Visit 6, after an average of 7.5 hours of training.
Evaluation of the assistance level provided by companion.
Assistance provided by the companion when mastering each basic skill on the checklist at initial learning, at the certification evaluation, during the additional practice session and when performing each test. A 3-point scale based on the Functional Independence Measure (FIM) score, tailored to the device and its progression stage will be used: 1. Maximal assistance: The companion provides support with both hands touching the device and/or the user almost continuously. 2. Moderate assistance - The companion provides support with one or both hands touching the device and/or the user intermittently. 3. Close contact guard/no assistance - The companion does not touch the device and/or the user but is close enough to assist if needed.
Time frame: Throughout the study and up until the end of Visit 9, after an average of 9 hours of training and 3 hours of assessment.
Overall Rating of Perceived Exertion (RPE) assessed with the Borg RPE scale by the users for the entire session.
The Borg scale rates the perceived exertion between 6 and 20 (very very light to very very hard exertion). The SCI users and their companions are asked to give their rating for the entire session, separately.
Time frame: At the end of visit 6 after an average of 7.5 hours of training, at the end of visit 7 after an average of 7.5 hours of training and 1.5 hours of assessment and at the end of visit 9, after an average of 9 hours of training and 3 hours of assessment.
Overall perceived safety with a 7-level Likert scale by the users on the entire session.
Each participant - SCI user and companion separately - will be asked to provide his/her level of agreement on the following statement: "I felt safe during the session." by using a 7-level agreement scale from 1: "Strongly disagree" to 7: "Totally agree".
Time frame: At the end of visit 6 after an average of 7.5 hours of training, at the end of visit 7 after an average of 7.5 hours of training and 1.5 hours of assessment and at the end of visit 9, after an average of 9 hours of training and 3 hours of assessment.
Up-right time in the device at each session
This measure is taken by the device itself.
Time frame: Throughout the study and up until the end of Visit 9, after an average of 9 hours of training and 3 hours of assessment.
Numbers of steps taken in the device at each session
The measure is taken by the device itself.
Time frame: Throughout the study and up until the end of Visit 9, after an average of 9 hours of training and 3 hours of assessment.
Distance walked in the device at each session
The measure is taken by the device itself.
Time frame: Throughout the study and up until the end of Visit 9, after an average of 9 hours of training and 3 hours of assessment.
Number of times the participants walk on each type of surface at each session
This data is collected by the device trainers at each session. Users are considered to have walked on a surface during a session if they have covered a minimum distance of 10 meters on that surface.
Time frame: Throughout the study and up until the end of Visit 9, after an average of 9 hours of training and 3 hours of assessment.
Perceived health benefits and overall satisfaction and motivation.
Perceived health benefits and overall satisfaction and motivation of the SCI users, assessed by a modified version of the Gagnon questionnaire. The statements under evaluation will be taken from the 41 statements originally found in the Gagnon questionnaire that encompass seven domains : * overall program satisfaction, * satisfaction with the robotic exoskeleton, * learnability of the robotic exoskeleton, * satisfaction with the program attributes, * perceived health benefits of walking with the robotic exoskeleton, * perceived risks and fears of walking with the robotic exoskeleton and * perceived motivation to engage in regular physical activity.
Time frame: At visit 9, after an average of 9 hours of training and 3 hours of assessment.
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No — The final datasets underlying publications from this research will not be made available to third parties, except as required by applicable law or for review by regulatory authorities and ethics committees.
Ran from Feb 2025 to primary completion in Jun 2026, 15 months.
Of 49 industry-sponsored interventional studies with no phase under Spinal Cord Injuries, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 28. This study's 15 months is close to that.
Counting every sponsor, half of 840 studies reached it within 36 months; a quarter within 17 and three quarters within 64.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 29, 2026: start Mar 2025 → Feb 2025, primary completion May 2026 → Jun 2026 and completion May 2026 → Jun 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Wandercraft